Bavarian Nordic A/S: Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
TMCnet11 小时
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved VIMKUNYA™ (Chikungunya Vaccine, Recombinant) for ...
Parents on MSN13 小时
New Therapy May Help Kids With Peanut Allergies Build Tolerance Over Time, Researchers Say
While this new treatment is promising, experts say families should still consult allergists to build a good game plan moving ...
Liver problems linked to supplement use are on the rise—here’s why
The supplement industry is booming—but so are serious health issues tied to taking these pills and powders. Here’s what ...
First for Women on MSN15 小时
Sluggish Thyroid? Eat These Foods to Minimize Your Symptoms
When it's overactive (hyperthyroidism), symptoms can include weight loss, anxiety and rapid heart rate. While medication is ...